Wednesday, May 17 2023
09:15 AM – 09:40 AM PT
Innate Immunity to AAV
Roland W Herzog, PhD. IU School of Medicine, Indianapolis, IN
Disclosures: R. Herzog: 1; Commercial Interest i.e. Company X; Prevail Therapeutics. 1; What was received? i.e. Honorarium; Honorarium, Consulting fee. 1; For what role? i.e. Speaker; Speaker, Scientific Advisor. 2; Commercial Interest i.e. Company X; Pfizer. 2; What was received? i.e. Honorarium; Honorarium. 2; For what role? i.e. Speaker; Speaker. 3; Commercial Interest i.e. Company X; Intellia-Regeneron collaboration. 3; What was received? i.e. Honorarium; Consulting fee. 3; For what role? i.e. Speaker; Scientific Advisor. 4; Commercial Interest i.e. Company X; Biomarin. 4; What was received? i.e. Honorarium; Honorarium. 4; For what role? i.e. Speaker; Speaker. 5; Commercial Interest i.e. Company X; Spark Therapeutics. 5; What was received? i.e. Honorarium; Grant. 5; For what role? i.e. Speaker; Scientific collaboration.